Navigation Links
FDA Grants Astellas Qualified Infectious Disease Product Designation for Isavuconazole for the Treatment of Invasive Aspergillosis
Date:12/3/2013

NORTHBROOK, Ill., Dec. 3, 2013 /PRNewswire/ -- Astellas Pharma US, Inc., a subsidiary of Astellas Pharma Inc. based in Tokyo, Japan, announced today that the U.S. Food and Drug Administration (FDA) designated isavuconazole as a Qualified Infectious Disease Product (QIDP) for the treatment of invasive aspergillosis. QIDP status provides priority review and a five-year extension of market exclusivity if a product receiving such a designation is approved in the United States. These incentives were granted under the 2012 U.S. Generating Antibiotic Incentives Now (GAIN) Act as part of the FDA Safety and Innovation Act.

The possibility of a five-year extension is in addition to the potential seven-year exclusivity based on isavuconazole's FDA orphan drug designation for the treatment of invasive aspergillosis. In the U.S., isavuconazole also received orphan drug designation for the treatment of zygomycosis, a life-threatening invasive fungal infection (IFI) caused by emerging molds.

"Invasive aspergillosis and zygomycosis are life threatening infections that typically occur in severely immunocompromised patients. Acceptance of Aspergillus as a qualified pathogen is a recognition of the need for new treatment options for patients infected with these fungi," said Bernie Zeiher, Senior Vice President and Global Therapeutic Area Head of Immunology and Infectious Diseases at Astellas Pharma Global Development, Inc. "We applaud the bipartisan Congressional supporters of the GAIN Act for their commitment to encouraging investment in treatments for these serious infectious diseases through the passage of this legislation."

IFIs are debilitating or life-threatening infections that attack internal tissues or organs and can spread through the bloodstream. Fungi commonly involved in IFIs include Aspergillus (molds) and Candida (yeasts).[1], [2] Invasive
'/>"/>

SOURCE Astellas Pharma US, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. RadSite Grants Accreditation to First Wave of MIPPA Program Applicants
2. NASDAQ Grants China Jo-Jo Drugstores 180-Day Extension to Regain Compliance with Bid Price Requirement
3. U.S. FDA Grants Orphan Drug Designation for KaloBios KB001-A in Treatment of Cystic Fibrosis Patients
4. FDA Grants 510(k) Clearance for Innovative Fuse Gastroscope from EndoChoice
5. Philanthropic Grants, Product Launches, Promising Partnerships, and Customer Satisfaction Rankings - Research Report on CVS Caremark, Walgreens, McKesson, AmerisourceBergen, and Cardinal Health
6. Life Technologies Awards Digital PCR Innovation Grants to Five Research Labs
7. FDA Grants Lillys Ramucirumab Priority Review as a Potential Single-Agent Treatment for Advanced Gastric Cancer
8. FDA Grants Orphan Drug Designation to Omeros OMS824 for Huntingtons Disease
9. European Union Grants a Good Manufacturing Practice Certificate to Nelson Laboratories
10. The Kenneth Rainin Foundation Continues its Commitment to Ending Inflammatory Bowel Disease, Awarding $1.5 Million in Research Grants
11. FDA Grants Orphan Drug Status To Eisais Investigational Compound (E7777) For Cutaneous T-Cell Lymphoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... , Suisse, October 1, 2014 ... clinique et dans le domaine de l,analyse des ... lancé aujourd,hui une solution de diagnostic in vitro ... une analyse complète de la mucoviscidose dans un ... et de caractériser tous les types de variantes ...
(Date:10/1/2014)... , October 1, 2014 ... Next Generation Sequencing (NGS) data analysis, today launches a ... cystic fibrosis analysis in a single NGS experiment. The ... all types of variants in a single NGS experiment ... it has not been possible to simultaneously analyse all ...
(Date:9/30/2014)... the health and safety of Canadians is our government,s highest priority.  ... tools at its disposal to help ensure that the drugs Canadians ... that end, Health Canada has taken ... of all drug products from three plants in ... Apotex Pharmachem India Pvt Ltd , Apotex Research Private Limited ...
Breaking Medicine Technology:Sophia Genetics lance une analyse complète du gène CFTR dans un essai clinique SGN 2Sophia Genetics lance une analyse complète du gène CFTR dans un essai clinique SGN 3Sophia Genetics Launches Full CFTR Analysis in Single Clinical Grade NGS Experiment 2Statement by the Honourable Rona Ambrose on the import ban of drug products from three plants in India 2
... Oct. 20 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc.,(Nasdaq: SSRX ) ... researching, developing, manufacturing and marketing,biopharmaceutical products, today announced the ... October 12, 2009. , At ... and Mr.,Moujia Qi to serve as members of the ...
... used to treat high blood pressure appear to be effective ... stable ischemic heart disease, according to a new comparative effectiveness ... A version of the analysis was posted in the ... Medicine . , Treatment featuring the two medications -- inhibitors ...
Cached Medicine Technology:High Blood Pressure Medicines Show Promise For Treating Heart Disease 2High Blood Pressure Medicines Show Promise For Treating Heart Disease 3
(Date:10/1/2014)... October 01, 2014 After a run ... "Beautiful Births", emerging filmmaker Jacqui Blue is continuing her ... discover the truth about natural birth. The documentary has ... over the world and has been an effective medium ... the topics highlighted in the film provide a wealth ...
(Date:10/1/2014)... This weekend Pope Francis drew world-wide attention ... Speaking to 40,000 seniors in St. Peter's Square in the ... "Violence against the elderly is as inhuman as that ... old people just discarded, victims of an abandonment that is ... throw-away culture that is hurting our world so much," he ...
(Date:10/1/2014)... 2014 The Oliver Law Group ... Other-Sonic Ultrasound Gel lawsuit web page ... litigation surrounding the 2011 Pseudomonas aeruginosa / bacterial ... Oak, Michigan, which was ultimately traced to the ... William Beaumont patients who allegedly became ill following ...
(Date:10/1/2014)... October 01, 2014 Looking for holiday gift ... care, is making gift giving easy this holiday season. Starting ... by Éminence to solve all shopping dilemmas. Choose from two ... ingredients to target the delicate eye area or to deliver ... Set and Eye Rescue Duo Gift Set are formulated to ...
(Date:10/1/2014)... 01, 2014 Indosoft, Inc., a leading provider ... that it has added support for Sangoma Lyra ... Indosoft have a history of bringing innovative products ... technology offers a significant benefit to those using Asterisk as ... now available to users of Q-Suite. , In the past ...
Breaking Medicine News(10 mins):Health News:Filmmaker Jacqui Blue's Beautiful Births Documentary, "Really Touched My Heart" 2Health News:Filmmaker Jacqui Blue's Beautiful Births Documentary, "Really Touched My Heart" 3Health News:Filmmaker Jacqui Blue's Beautiful Births Documentary, "Really Touched My Heart" 4Health News:Pope Francis Shines New Spotlight on Neglect of Elderly, Survey Finds Elder Self-Neglect is a Growing and Hidden Problem in U.S. says NAPGCM 2Health News:Pope Francis Shines New Spotlight on Neglect of Elderly, Survey Finds Elder Self-Neglect is a Growing and Hidden Problem in U.S. says NAPGCM 3Health News:Other-Sonic Ultrasound Gel Lawsuit Page Launched by The Oliver Law Group P.C. To Provide Information On Pseudomonas Outbreak Linked to Recalled Ultrasound Gel 2Health News:Other-Sonic Ultrasound Gel Lawsuit Page Launched by The Oliver Law Group P.C. To Provide Information On Pseudomonas Outbreak Linked to Recalled Ultrasound Gel 3Health News:Other-Sonic Ultrasound Gel Lawsuit Page Launched by The Oliver Law Group P.C. To Provide Information On Pseudomonas Outbreak Linked to Recalled Ultrasound Gel 4Health News:Éminence Organic Skin Care Launches Limited Edition Spa Gift Sets for the Holiday Season 2Health News:Éminence Organic Skin Care Launches Limited Edition Spa Gift Sets for the Holiday Season 3Health News:Indosoft Announces Q-Suite Support For Sangoma Lyra 2
... space technology is helping doctors diagnose and monitor ... its early stages, before it causes heart attacks ... the country are using ArterioVision software initially developed ... along with a standardized, painless, non-invasive ultrasound examination ...
... J. Fox Foundation for Parkinson's Research announced $710,000 in ... leveraging existing data and patient populations to initially characterize ... that may differ in onset, progression and response to ... of Parkinson's disease -- for patients, researchers and clinicians ...
... of concern as most of them are related to mental ... problems due to which people abstained from work. ... Development (CIPD) on about 30,000 workers revealed that mental illness ... muscle related problems like bad back. ,The study ...
... N.J., Centocor, Inc. and Schering-Plough Corporation (NYSE: SGP) ... approved a new indication for REMICADE(R) (infliximab) allowing ... (CD) in pediatric patients aged 6 to 17 ... including a corticosteroid, an immunomodulator and primary nutrition ...
... Annual Meeting of the Society for Vascular Surgery, ... worldwide launch of the Cordis AVIATOR (TM) Plus ... for patients with carotid and or renal artery ... and low profile .014 inch rapid exchange (RX) ...
... Ozzy Osbourne says that getting rid of smoking was more ... and alcohol . ,The former hellraiser, who quit ... he has not gotten hooked to smoking again.,He revealed that ... himself with nicotine patches. ,"They're all a b**ger ...
Cached Medicine News:Health News:NASA Technology Helps Detect and Treat Heart Disease and Strokes 2Health News:NASA Technology Helps Detect and Treat Heart Disease and Strokes 3Health News:Michael J. Fox Foundation Awards $710,000 to Understanding of Parkinson's Disease Subtypes 2Health News:Mental Illness Foremost Reason for Absenteeism 2Health News:Remicade(R) Get Approval for First and Only Biologic Treatment for Pediatric Crohn's Disease 2Health News:New Balloon Catheter Available Worldwide for Carotid and Renal Angioplasty 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: